Nabriva Therapeutics plc NBRV

Set alert

Price alert · NBRV

All alert types
1.42 +1.42 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
4.96M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.18
Beta
1.55
Short ratio
6.12
Inst. own
9.21%
Dividend
0.00
Ex-div date
Earnings
Aug 2, 2023
50-d avg
1.57
200-d avg
1.83
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NBRV has not been loaded yet. Try again in a moment.

Analyst view

Consensus: underperform

Underperform
Price target (mean) 0.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NBRV analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.00-6.000.0%10.57M+14.1%0
Next quarter0.000.00 – 0.00-5.000.0%00.0%0
Current year0.000.00 – 0.000.000.0%36.94M+27.8%0
Next year0.000.00 – 0.000.000.0%70.77M+91.6%0

Upgrades and downgrades

The latest rating changes

NBRV analyst upgrades and downgrades
DateFirmActionFromTo
Dec 7, 2020Morgan StanleyMaintained—Equal-Weight
Apr 9, 2020H.C. WainwrightDowngradeBuyNeutral
Apr 9, 2020HC Wainwright & Co.DowngradeBuyNeutral
Apr 8, 2020NeedhamDowngradeBuyHold
Mar 19, 2020WedbushDowngradeOutperformNeutral
Mar 17, 2020Morgan StanleyDowngradeOverweightEqual-Weight
Mar 13, 2020NeedhamMaintained—Buy
Mar 27, 2019Gabelli & Co.DowngradeBuySell
Aug 27, 2018Bank of AmericaMaintainedBuyBuy
May 22, 2018Bank of AmericaMaintainedBuyBuy
Jan 17, 2018Morgan StanleyInitiated—Overweight
Aug 28, 2017H.C. WainwrightMaintained—Buy
Aug 25, 2017SunTrust Robinson HumphreyInitiated—Buy
Sep 8, 2016H.C. WainwrightInitiated—Buy
Jan 27, 2016Gabelli & Co.Initiated—Buy
Oct 13, 2015RBC CapitalInitiated—Outperform
Oct 13, 2015Leerink SwannInitiated—Outperform
Oct 12, 2015NeedhamInitiated—Buy